COPD: it is time to change!

Area of Science:

• Pulmonary Medicine
• Respiratory Health
• Internal Medicine

Background:

• Chronic Obstructive Pulmonary Disease (COPD) is a significant global health burden, causing widespread disability, morbidity, and mortality.
• Current COPD management often focuses on airflow obstruction, symptoms, and exacerbation frequency, potentially overlooking underlying disease drivers.
• Existing treatment guidelines may not fully address the heterogeneity of COPD or long-term patient risk stratification.

Purpose of the Study:

• To propose a revised therapeutic approach for COPD management.
• To emphasize tailoring treatments based on the prevalent underlying disease and future risk.
• To improve the prevention and management of COPD exacerbations.

Main Methods:

• The study suggests a paradigm shift in COPD treatment strategies.
• It advocates for prioritizing therapy based on the specific underlying condition causing COPD.
• It recommends personalized treatment adjustments considering disease severity and patient age.

Main Results:

• Current treatment approaches may be suboptimal by not addressing the root causes of COPD.
• A tailored, disease-specific approach could potentially "freeze" disease progression more effectively.
• Focusing on prevalent disease types and exacerbation patterns can lead to more specific and effective interventions.

Conclusions:

• COPD therapy should be individualized, starting with the underlying prevalent disease, irrespective of FEV1 or dyspnea severity.
• Future risk assessment and tailored interventions are crucial for managing COPD progression.
• Enhanced recognition and prevention of specific exacerbation types in frequent exacerbators are necessary for better COPD management.